1US Department of Health and Human Services, National Institutes of Health. Chronic Obstructive Pulmonary Disease,2003,3:03 -5229.
2Anthonisen NR, Manfreda J,Warren CPW,et al. Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease. Ann Intern Med, 1997,106 : 196 - 204.
3Saetta S, Di Stefano A, Maestrelli P, et al. Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy,2006,26:766 -774.
4Keating VM, Collins PD, Scott DM, et al. Differences in interleukin -8 and tumor necrosis factor-αinduced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med,2006,153:530 - 534.
5Montuschi P, Collins JV, Ciabattoni G, et al. Exhaled 8-iso-prostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med,2000,162:1175 - 1177.
6Hill AT, Campbell EJ, Hill SL, et al. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med ,2000,109:288 - 295.
7Miravitlles M. Exacerbation of chronic obstructive pulmonary disease: when are bacterial important? Eur Respir J,2002,20:36 - 39.
8Paggiaro PL, DaMe R, Bakran I, et al. Multicentre randomized placebo-controlled trial of inhaled fluticasone proprionate in patients with chronic obstructive pulmonary disease. Lancet,2003,351:73 -80.
9Doem GV, Pfaller MA, Kugler K, et al. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY Antimicrobial Surveillance Program. Clin Infect Dis, 1998,27:764 - 770.
10Kerstjens HAM, Grunsven PM, Renkema TEJ, et al. Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease : a meta-analysis. Thorax,2004,54:7 - 14.
